Rainier Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rainier Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-75,720	Closed	-$10.1M	–	184
2015 Q3	$10.1M	Sell	75,720 -62,730	-45%	-$10.8M	0.37%	123
2015 Q2	$24.4M	Sell	138,450 -41,620	-23%	-$7.47M	0.77%	36
2015 Q1	$31.1M	Sell	180,070 -25,290	-12%	-$4.34M	0.62%	65
2014 Q4	$33.6M	Sell	205,360 -20,260	-9%	-$3.36M	0.6%	58
2014 Q3	$36.2M	Buy	225,620 +48,160	+27%	+$7.4M	0.6%	64
2014 Q2	$26.1M	Sell	177,460 -35,800	-17%	-$4.96M	0.4%	100
2014 Q1	$29.6M	Buy	+213,260	New	+$32.1M	0.35%	98

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Rainier Investment Management's JAZZ Position: Q4 2015 in Review

Rainier Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 75,720 shares — an estimated $10.1M sold.

Rainier Investment Management first reported a position in JAZZ in Q1 2014 and held it in 7 quarters. The position peaked at $36.2M in Q3 2014. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

Rainier Investment Management reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Rainier Investment Management sold 75,720 Jazz Pharmaceuticals shares in Q4 2015, an estimated $10.1M.
Rainier Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 7 quarters.
Rainier Investment Management's Jazz Pharmaceuticals position peaked at $36.2M in Q3 2014.
345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Rainier Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.